Anaerobic infections of the female genital tract.
The anaerobic flora of the cervix undergoes cyclic change during menstruation and pregnancy. The etiopathogenesis of anaerobic infections of the female genital tract is described. The in vitro susceptibility of the cervical microflora to various antibiotics presented and treatment of anaerobic infections of the female genital tract briefly is discussed.
D000031:Abortion, Septic; D000038:Abscess / Q000382:microbiology; D000290:Adnexa Uteri / Q000382:microbiology; D000653:Amniotic Fluid / Q000382:microbiology; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology*; D002169:Campylobacter Infections / Q000382:microbiology; D002168:Campylobacter fetus / Q000302:isolation & purification; D005260:Female; D005315:Fetal Diseases / Q000382:microbiology; D005831:Genital Diseases, Female / Q000382:microbiology*; D005836:Genitalia, Female / Q000382:microbiology*; D006089:Gram-Negative Anaerobic Bacteria / Q000302:isolation & purification; D006801:Humans; D007231:Infant, Newborn; D007434:Intrauterine Devices / Q000009:adverse effects; D008598:Menstruation; D008826:Microbial Sensitivity Tests; D000292:Pelvic Inflammatory Disease / Q000382:microbiology; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000382:microbiology; D011645:Puerperal Infection / Q000382:microbiology; D018805:Sepsis / Q000382:microbiology
D000900:Anti-Bacterial Agents